# A Post Market Study on the Use of Cormatrix® Cangaroo ECM® (Extracellular Matrix) Envelope

> **NCT02530970** · — · COMPLETED · sponsor: **Elutia Inc.** · enrollment: 1025 (actual)

## Conditions studied

- Cardiovascular Disease

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02530970
- **Lead sponsor:** Elutia Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-10
- **Primary completion:** 2017-12
- **Final completion:** 2018-04
- **Target enrollment:** 1025 (ACTUAL)
- **Last updated:** 2023-07-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02530970

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02530970, "A Post Market Study on the Use of Cormatrix® Cangaroo ECM® (Extracellular Matrix) Envelope". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02530970. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*